| http://www.w3.org/ns/prov#value | - Therapeutic doses of Bricasma very seldom produce these effects.IndicationFor the release of bronchospasm in bronchial asthma, chronic bronchitis, emphysema and other diseases of the lung, where bronchoconstriction is a complicating factor.ContraindicationsPatients with a history of hypersensitivity to any of its component or sympathomimetic amines.Patients with thyrotoxicosis should use Bricasma
|
